Press "Enter" to skip to content

New patent expiration for Eli Lilly drug BAQSIMI

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Eli Lilly drug BAQSIMI

Annual Drug Patent Expirations for BAQSIMI
Annual Drug Patent Expirations for BAQSIMI

Baqsimi is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

BAQSIMI drug price trends.

This drug has sixty-seven patent family members in thirty-eight countries.

The generic ingredient in BAQSIMI is glucagon. One supplier is listed for this compound. Additional details are available on the glucagon profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Eli Lilly drug BAQSIMI
    DrugPatentWatch - Make Better Decisions